ADMA stock surges 76.2% in three months on strong performance and high growth prospects. It recently hit its 52-week high ...

The latest trading session saw Adma Biologics (ADMA) ending at $19.98, denoting a +1.22% adjustment from its last day's close. This move outpaced the S&P 500's daily loss of 0.19%. At the same time, ...

WASHINGTON — Sen. Bill Cassidy (La.), a key Republican senator with seats on the chamber’s health and finance committees, ...

Physicians should track clinical remission in patients with asthma on biologics and monitor for EGPA symptoms, as ...

Analysts have recently evaluated ADMA Biologics and provided 12-month price targets. The average target is $18.25, ...

Forge Biologics is promoting from within as the third and final co-founder steps away less than a year after the biotech's ...

The choice of scaling strategy—“up,” “out,” or “down”—depends on a biomanufacturer’s business strategy and product demand ...

IntroductionIn recent years, the biologics market has witnessed exponential growth, driven by the increasing demand for ...

HCW Biologics Inc. (NASDAQ:HCWB)，一家制药公司，周四宣布解聘其独立审计公司Grant Thornton LLP。董事会审计委员会确认的这一决定并非由于在会计原则或实务、财务报表披露或审计范围或程序方面存在任何争议。 Grant Thornton审计的公司截至2022年和2023年12月31日的财务报表不包含任何不利意见或免责声明。然而，报告中包含了一个解释性段落，强 ...

The Frost & Sullivan Global Leadership Award recognizes enterprises' outstanding performance and exceptional achievements in ...

Innovent Biologics has made the case that its checkpoint inhibitor-cytokine fusion protein has a future in colorectal cancer.

(RTTNews) - Innovent Biologics Inc. (IVBXF.OB) said that Phase 3 clinical trial results demonstrated the superiority of mazdutide to dulaglutide in both glycemic control and body weight reduction in ...